Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1186/1752-1947-8-250.pdf
Reference13 articles.
1. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA: Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986, 29: 515-524. 10.1002/art.1780290409.
2. Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H, Bein M, Smith JW, Roberts N, Cabeen W: Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med. 1983, 75: 65-74.
3. MacLean MR: Endothelin-1: a mediator of pulmonary hypertension?. Pulm Pharmacol Ther. 1998, 11: 125-132. 10.1006/pupt.1998.0126.
4. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ: Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet. 2001, 358: 1119-1123. 10.1016/S0140-6736(01)06250-X.
5. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Michael L, Gérald S: Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002, 346: 896-903. 10.1056/NEJMoa012212.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis;Seminars in Liver Disease;2024-02
2. Liver injury due to endothelin receptor antagonists: a real-world study based on post-marketing drug monitoring data;Therapeutic Advances in Respiratory Disease;2024-01
3. Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review;Frontiers in Pharmacology;2021-10-27
4. Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta‐analysis;Journal of Clinical Pharmacy and Therapeutics;2021-07-28
5. Bile acids in drug induced liver injury: Key players and surrogate markers;Clinics and Research in Hepatology and Gastroenterology;2016-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3